VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
102 hedge funds and large institutions have $316M invested in Viracta Therapeutics, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% less capital invested
Capital invested by funds: $317M → $316M (-$1.03M)
Holders
102
Holding in Top 10
1
Calls
$10.9M
Puts
$4.26M
Top Buyers
| 1 | +$7.6M | |
| 2 | +$2.01M | |
| 3 | +$1.59M | |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$1.52M |
| 5 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
+$1.49M |
Top Sellers
| 1 | -$6.06M | |
| 2 | -$3.06M | |
| 3 | -$2.31M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.28M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$1.07M |